Skip to content

Press Releases

Public Relations: Andrew Noble

April 11, 2024

UK Biobank and DNAnexus Collaboration Earns Bio-IT World 2024 Innovative Best Practices Global Impact Award for 500,000 Whole Genomes Data Release

DNAnexus will be showcasing its innovative Precision Health Data Cloud and large-scale analysis tools during the Bio-IT World Conference in booth #28.
Read More
April 10, 2024

DNAnexus and Oracle Collaborate to Advance Precision Health

We are excited to announce we have teamed up with Oracle to advance precision health by connecting our respective ecosystems. The DNAnexus platform will be seamlessly available to global Oracle Cloud Infrastructure, Oracle Health, and Oracle Database customers. In addition, customers will be able to use OCI integration services for their healthcare applications. DNAnexus customers will be able to leverage Oracle’s expertise in accelerating AI pipelines and its industry partnerships to bring global customers even faster genomic analysis and better AI models.

Read More
March 19, 2024

DNAnexus Adds NVIDIA NIM and CUDA-X Microservices to Precision Health Data Cloud to Accelerate Drug Discovery and Improve Patient Care

New Universal DeepVariant is one microservice compatible across multiple sequencing platforms and is designed to deliver more than 50x acceleration compared to CPU

Read More
March 18, 2024

DNAnexus to Showcase the Power of High-Value Multi-Omics Data at the Precision Medicine in IBD Summit

Co-founder of Ovation to share how researchers are using DNAnexus’ Precision Health Data Cloud to streamline analysis, identify optimal therapeutic targets, and advance drug discovery.

Read More
February 21, 2024

DNAnexus and Curio Bioscience Announce Collaboration to Streamline and Simplify Data Analysis for Large-Scale Spatial Transcriptomics Projects

Combination of Curio Seeker with Precision Health Data Cloud provides scientists with a secure and scalable solution for managing and sharing high-resolution, spatially resolved gene expression data.

Read More


December 06, 2023

World’s largest genetic project opens the door to new era for treatments and cures: UK Biobank’s major milestone

In a momentous landmark for medical research, UK Biobank has today unveiled incredible new data from whole genome sequencing of its half a million participants. This is set to drive the discovery of new diagnostics, treatments and cures and, uniquely, is available to approved researchers worldwide, via a protected database containing only de-identified data (e.g. name, address, date of birth, name of GP and more stripped out).

Read More
March 07, 2023

DNAnexus included in Fast Company's 10 most innovative biotech companies of 2023

Among the 2023 Most Innovative Companies in Biotech, Fast Company is recognizing breakthroughs in DNA sequencing and spatial transcriptomics, along with innovations in biological-specimen sourcing, cell-separation technology, and the production of synthetic antibodies. 

Read More
March 18, 2022

Blackstone Growth Leads $200 Million Investment in DNAnexus

DNAnexus, founded in 2010, has a platform that puts massive sets of genomic data into the cloud so they can be accessed and analyzed by researchers who may be unable to process that volume onsite.
Read More

"Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases."

James R. Downing
President & CEO
St. Judes Children’s Research Hospital